5671 - 5680 of 6295 Results
Title
Year
-
OPENTitle: Stress and mindfulness in Parkinson’s disease – a survey in 5000 patientsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-020-00152-9Best OA location URL: https://www.nature.com/articles/s41531-020-00152-9.pdfCitation Count: 61
-
OPENTitle: The anti-parkinsonian drug zonisamide reduces neuroinflammation: Role of microglial Nav 1.6Journal Name: Experimental NeurologyPublisher: Elsevier BVVol: 308Issue #:Start Page: 111End Page: 119Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2018.07.005Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7404626Citation Count: 38
-
OPENTitle: Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primatesJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1186/s40478-017-0451-7Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-017-0451-7Citation Count: 41
-
OPENTitle: Anti‐Parkinsonian and anti‐dyskinetic profiles of two novel potent and selective nociceptin/orphanin FQ receptor agonistsJournal Name: British Journal of PharmacologyPublisher: WileyVol: 175Issue #: 5Start Page: 782End Page: 796Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/bph.14123Best OA location URL: https://bpspubs.onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.14123Citation Count: 20
-
OPENTitle: MR‐based age‐related effects on the striatum, globus pallidus, and thalamus in healthy individuals across the adult lifespanJournal Name: Human Brain MappingPublisher: WileyVol: 40Issue #: 18Start Page: 5269End Page: 5288Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/hbm.24771Best OA location URL: https://doi.org/10.1002/hbm.24771Citation Count: 68
-
OPENTitle: Olfactory impairment predicts cognitive decline in early Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 25Issue #:Start Page: 45End Page: 51Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2016.02.013Best OA location URL: http://doi.org/10.1016/j.parkreldis.2016.02.013Citation Count: 111
-
OPENTitle: β-catenin aggregation in models of ALS motor neurons: GSK3β inhibition effect and neuronal differentiationJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 130Issue #:Start Page: 104497End Page: 104497Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.nbd.2019.104497Best OA location URL: https://repositorio.uchile.cl/handle/2250/172258Citation Count: 18
-
OPENTitle: Pathogenic Pathways in Early-Onset Autosomal Recessive Parkinson's Disease Discovered Using Isogenic Human Dopaminergic NeuronsJournal Name: Stem Cell ReportsPublisher: Elsevier BVVol: 14Issue #: 1Start Page: 75End Page: 90Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.stemcr.2019.12.005Best OA location URL: http://www.cell.com/article/S2213671119304448/pdfCitation Count: 49
- Exploring the Potential Imaging Biomarkers for Parkinson’s Disease Using Machine Learning Approach2024OPENTitle: Exploring the Potential Imaging Biomarkers for Parkinson’s Disease Using Machine Learning ApproachJournal Name: BioengineeringPublisher: MDPI AGVol: 12Issue #: 1Start Page: 11End Page: 11Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/bioengineering12010011Best OA location URL: https://www.mdpi.com/2306-5354/12/1/11/pdf?version=1735311941Citation Count: 0
-
OPENTitle: Motor and nonmotor symptoms in patients treated with 24-hour daily levodopa-carbidopa intestinal gel infusion: Analysis of the COmedication Study assessing Mono- and cOmbination therapy with levodopa-carbidopa inteStinal gel (COSMOS)Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 105Issue #:Start Page: 139End Page: 144Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.08.002Best OA location URL: http://www.prd-journal.com/article/S1353802022002553/pdfCitation Count: 10